Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Trends in Healthcare Access in Japan during the First Wave of the COVID-19 Pandemic, up to June 2020

Int J Environ Res Public Health. 2021-03; 
Koji Makiyama, Takayuki Kawashima, Shuhei Nomura, Akifumi Eguchi, Daisuke Yoneoka, Yuta Tanoue, Yumi Kawamura, Haruka Sakamoto, Stuart Gilmour, Shoi Shi, Kentaro Matsuura, Shinya Uryu, Masahiro Hashizume
Products/Services Used Details Operation
Gene Synthesis … These pathways can then be optimized by platform companies such as Ginkgo Bioworks, Genscript and Zymergen to improve the production efficacy of desired molecules. In parallel, it is also recognized that the combination of bio- and conventional chemical synthesis offers … Get A Quote

摘要

We evaluated the impact of the new coronavirus disease (COVID-19) on healthcare access in Japan in terms of the number of outpatients and hospitalized patients as well as the length of hospital stays, during the first wave of the pandemic, up to June 2020. This observational study evaluated the monthly average number of outpatients per day at hospitals, the average number of hospitalized patients per day, and the average length of hospital stays per patient, from December 2010 to June 2020, using the hospital reports data, which are open aggregated data on the utilization of hospitals from the Ministry of Health, Labour and Welfare. These numbers were compared with those from the same period of previous years, ... More

关键词

COVID-19, Japan, healthcare access
XML 地图